Synthesis and Characterization of new Azecine-Derivatives as Potential Neuroleptics

Abstract

Dibenzo- and benzindolo-azecines represent a class of potential neuroleptics. To characterize the effectiveness at the dopamine and 5-HT_2A-receptor representative structures were synthesized and tested by radio ligand binding studies, in vivo and in vitro studies.

Neuroleptic potency and the risk of side effects of the prodrug 7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecin-3-yl isobutyrate, an ester derivative of the most promising azecine 7-methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecin-3-ol (LE404), was tested in vivo concerning conditioned avoidance response inhibition, locomotor activity and triggering of catalepsy vs. haloperidol as a reference. Also ester hydrolysis was examined using porcine liver esterase to thereby obtain an indication of the stability of the prodrug in vivo. An HPLC method was developed for purity control and determination of octanol/water-distribution coefficients.

It has been shown that the tested substances in their efficacy are comparable to haloperidol and risperidone, but the therapeutic index in most cases is larger. Esterification as a prodrug principle leads to significantly prolonged effectiveness.

Key words

azecines - LE404 - antipsychiotics - CAR - locomotor activity - esterase cleavage

• References

• 1 Emilien G, Maloteaux JM, Geurts M. et al. Dopamine receptors-physiological understanding to therapeutic intervention potential. Pharmacol Ther 1999; 84: 133-156
• 2 Bonnot O, Dumas N. Schizophrenic disorders in adolescence. Rev Prat 2014; 64: 499-504
• 3 Carpenter Jr WT, Buchanan RW. Schizophrenia. N Engl J Med 1994; 681-690
• 4 Abi-Dargham A, Laruelle M. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: Insights from brain imaging studies. Eur J Psychiatry 2005; 20: 15-27
• 5 Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 2004; 3: 353-359
• 6 Leucht S, Pitschel-Walz G, Abraham D. et al. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res 1999; 35: 51-68
• 7 Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989; 251: 238-246
• 8 Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry 2001; 158: 360-369
• 9 Witt T, Hock FJ, Lehmann J. 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: A new heterocyclic system and a new lead compound for dopamine receptor antagonists. J Med Chem 2000; 43: 2079-2081
• 10 Hoefgen B, Decker M, Mohr P. et al. Dopamine/Serotonin Receptor Ligands. 10:1 SAR studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist. J Med Chem 2006; 49: 760-769
• 11 Schulze M, Siol O, Robaa D. et al. Molecular combination of the dopamine and serotonin scaffolds yield in novel antipsychotic drug candidates – characterization by in vivo experiments. Drug Res 2012; 62: 252-260
• 12 Kassack MU, Hofgen B, Decker M. et al. Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist. Naunyn Schmiedeberg‘s Arch Pharmacol 2002; 366: 543-550
• 13 Mohr P, Decker M, Enzensperger C. et al. Dopamine/serotonin receptor ligands. 12(1): SAR studies on hexahydro-dibenz[d,g]azecines lead to 4-chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the first picomolar D5-selective dopamine-receptor antagonist. J Med Chem 2006; 49: 2110-2116
• 14 Enzensperger C, Kilian S, Ackermann M. et al. Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists. Bioorg Med Chem Lett 2007; 17: 1399-1402
• 15 Robaa D, Eldin AbulAzm S, Lehmann J. et al. A novel non-phenolic dibenzazecine derivative with nanomolar affinities for dopamine receptors. Chem Biodivers 2011; 8: 431-439
• 16 Kassack MU, Hofgen B, Lehmann J. et al. Functional screening of G protein-coupled receptors by measuring intracellular calcium with a fluorescence microplate reader. J Biomol Screen 2002; 7: 233-246
• 17 Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol (Copenh.) 1982; 51: 321-329
• 18 de Oliveira L, Cunha AO, Mortari MR. et al. Cataleptic activity of the denatured venom of the social wasp Agelaia vicina (Hymenoptera, Vespidae) in Rattus norvegicus (Rodentia, Muridae). Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 198-203
• 19 Ahlenius S, Hillegaart V. Involvement of extraphyramidal motor mechanisms in the suppression of locomotor-activity by antipsychotic-drugs - a comparison between the effects produced by presynaptic and postsynaptic inhibition of dopaminergic neurotransmission. Pharmacol Biochem Behav 1986; 24: 1409-1415
• 20 ICH Guideline, I., Topic Q 2 B/validation of analytical procedures: Methodology. 1996; http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html 20.08.2016
• 21 OECD Guideline 117, OECD Guideline for testing of chemicals. 1989; http://www.oecd.org/chemicalsafety/risk-assessment/1948169.pdf 10.09.2016
• 22 Hansch CM, Muir RM, Fujita T. et al. The correlation of biological activity of plant growth regulators and chloromycetin derivatives with Hammett constants and partition coefficients. J Am Chem Soc 1963; 2817-2824
• 23 Brandstrom A. The use of distribution coefficients in predicting lipid concentrations of drugs. Acta. Pharm. Suec 1964; 1: 159-164
• 24 Hansch C, Anderson SM. The effect of intramolecular hydrophobic bonding on partition coefficients. J Org Chem 1967; 2583-2586
• 25 Hansch C, Leo A. Pomona College Medicinal Chemistry Project, Log P Database, 1987. Claremont, CA 91711.
• 26 http://www.drugbank.ca/drugs/DB00721 22.03.2011
• 27 Deutsche Gesellschaft für Psychiatrie, Psychiotherapie und Nervenheilkunde (DGPPN). Behandlungsleitlinie Schizophrenie, S3 Praxisleitlinien in Psychiatrie und Psychotherapie. Vol. 1. 2006, Steinkopff Darmstadt.
• 28 MacDougall C, Guglielmo BJ. Pharmacokinetics of valaciclovir. J Antimicrob Chemother 2004; 53: 899-901
• 29 Dhokchawle BV, Tauro SJ, Bhandari AB. Ester prodrugs of ketoprofen: Synthesis, hydrolysis kinetics and pharmacological evaluation. Drug Res 2016; 66: 46-50